Dr. Lal PathLabs Ltd (BOM:539524)
₹ 3032.8 -65.45 (-2.11%) Market Cap: 252.57 Bil Enterprise Value: 242.94 Bil PE Ratio: 63.01 PB Ratio: 12.63 GF Score: 99/100

Q2 2020 Dr. Lal PathLabs Ltd Earnings Call Transcript

Nov 08, 2019 / 12:00PM GMT
Release Date Price: ₹1451.8 (-2.91%)
Operator

Good day, ladies and gentlemen, and welcome to the Q2 and H1 FY '20 Earnings Conference Call of Dr. Lal PathLabs.

(Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Nishid Solanki of CDR India. Thank you, and over to you, sir.

Nishid Solanki
CDR India - IR Manager

Thank you. Good evening, everyone, and a warm welcome to Dr. Lal PathLabs Q2 and H1 FY '20 Earnings Conference Call. Joining us today are Honorary Brigadier, Dr. Arvind Lal, Chairman and Managing Director; Dr. Om Prakash Manchanda, Whole Time Director and CEO; and Mr. Ved Parakash Goel, CFO. We also have with us, Mr. Bharath, CEO India Business; and Mr. Rajat Kalra, Company Secretary and Head of Investor Relations.

Before we begin the call, I would like to highlight that some of the statements made on the call today to be forward-looking in nature. Actual results may vary from these statements. A detailed disclosure in this regard is available in the results presentation, which was shared earlier.

I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot